Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Endothelix logo — VENDYS® measures vascular function using small temperature s...

Endothelix

VENDYS® measures vascular function using small temperature sensors attached to the fingertips.

Founded 2003 8 employees Series A Total: $500.00K Biotechnology, Developer Tools +2

General Information

Company Name Endothelix
Founded Year 2003
Employees 8
Industries Biotechnology, Developer Tools, Health Care +1
Funding Stage Series A
Social

Get notified when Endothelix moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Endothelix

Endothelix, Inc. is a cardiovascular device company based in Houston, Texas and is focused on non-invasive vascular function measurement. The company originated from the Texas Medical Center-Houston from a collaborative project between the Texas Heart Institute and The University of Texas Health Science Center at Houston. Endothelix received a $1 million award from the Texas Emerging Technology Fund to develop the VENDYS® technology. Endothelix’s first product is VENDYS®, a non-invasive, inexpensive, and easy to use vascular function test. VENDYS® is FDA approved and is currently marketed throughout the United States, Europe and Canada. The company has a pipeline of innovative products.

Taxonomy: cardiovascular device, vascular function measurement, non-invasive technology, FDA approved, innovative products, Texas Medical Center, collaborative project, Texas Heart Institute, University of Texas Health Science Center, Texas Emerging Technology Fund, VENDYS technology, biomedical engineering, startup

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 1
Investor
17 Jul 2006

Endothelix Alternatives & Competitors

Endothelix vs
Mid Atlantic Finance Company
Mid Atlantic Finance Company United States

Mid Atlantic Finance Company (MAF) is a non prime financial services leader with over 5 billion in f...

136 employees
Financial Services
Endothelix vs
Delphi Diagnostics Inc.
Delphi Diagnostics Inc. United States

Innovative, unique tests to guide therapy decisions for breast cancer patients.

Series Unknown
10 employees
Health Care
Endothelix vs
Vital Heart & Vein
Vital Heart & Vein United States

Beating heart disease.

126 employees
Health Care

FAQ About Endothelix

VENDYS® measures vascular function using small temperature sensors attached to the fingertips.
Endothelix was founded in 2003.
Endothelix operates in the following industries: Biotechnology, Developer Tools, Health Care, Information Technology.
Endothelix has approximately 8 employees.
Endothelix has completed 1 funding round, raising a total of $500.00K. The latest funding stage is Series A.
Top alternatives and competitors to Endothelix include Mid Atlantic Finance Company, Delphi Diagnostics Inc., Vital Heart & Vein, Soliton, Inc., Varocto Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Endothelix and Mid Atlantic Finance Company are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Endothelix and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes